Mercer Global Advisors’s Propanc Biopharma PPCB Stock Holding History

Mercer Global Advisors’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Buy	+1	New	+$2	﹤0.01%	6097

Other funds holding PPCB

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Mercer Global Advisors's PPCB Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Propanc Biopharma (PPCB) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #6097 among its holdings.

2 funds tracked by Wall St. Rank hold PPCB as of Q2 2026.

Mercer Global Advisors held 1 share of Propanc Biopharma worth $2 as of Q2 2026.
Propanc Biopharma was a new Mercer Global Advisors position in Q2 2026.
Propanc Biopharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6097 holding.
2 funds tracked by Wall St. Rank held Propanc Biopharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.